Manufacturing Considerations For Viral & Non-Viral Platform Selection

In this webinar, a panel of experts spanning the lentiviral vector (LVV), exosome and oncolytic virus fields will discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies.

Key learning points:

• Advanced therapy technology platform selection criteria
• Process and product development challenges and solutions at the cutting edge of the LVV, exosome, and oncolytic virotherapy fields
• Recent and likely future evolution of viral and non-viral DSP toolkits